Procter And Gamble Health reported a web revenue of Rs 15.8 crore in March quarter of fiscal 2020-21
Procter AndĀ Gamble Health Limited introduced its January-March quarter outcomes for the monetary 12 months 2020-21 on Thursday, May 6. According to a regulatory submitting by the corporate to the inventory exchanges at the moment, Procter And Gamble Health reported a web revenue of Rs 15.8 crore within the March quarter of the fiscal 12 months 2020-21, in comparison with Rs 46.5 crore within the corresponding quarter final 12 months, registeringĀ a 66 per cent decline in webĀ revenue. Procter and Gamble registeredĀ gross sales of RsĀ 214 crores within the fourth and final quarter of fiscal 2020-21, marking a decline of 4 per cent in comparison with the corresponding quarter final 12 months.
According to the corporate, the gross sales within the quarter have been affectedĀ resulting fromĀ inventory challenges and a better earlierĀ 12 months’s base on account of exports gross sales phasing throughout the identical quarter final 12 months. Procter and Gamble reported gross sales for the 9 months ending March 2021 at Rs 710 crores, up by 5 per cent on a year-on-year foundation.
Ā The web revenue within the March quarter was affected resulting from decrease gross sales and decrease expense base final 12 months, supported by the supply true-ups in addition to reversals, stated the agency in its assertion.
The revenue after tax or PAT for the 9 months ending MarchĀ 2021 stood at RsĀ 142.9 crore, in comparison with Rs 120.4 crores, marking aĀ 19 9 per centĀ progress on a year-on-year foundation. On Thursday, shares of Procter and Gamble Health settled 0.67 per cent decrease at Rs 6,270.50 apiece on the BSE.
Procter and Gamble Health opened on the BSE at Rs 6,398, registering an intra day excessive of Rs 6,398 and an intra day low of Rs 6,231 in the course of the buying and selling session.
